Anthim letter contract
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00073
- Awardee
-
Elusys Therapeutics Inc. UEI ELP1DCK8L191 Part of Nighthawk Biosciences, Inc.
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $79,947,200
Award facts
- Opportunity
-
- Award of Anthim (obiltoxaximab) 600mg/6ml for Injection Pre-Solicitation · 6282021 · Posted Jul 24, 2021
- Contract value 100% obligated
- $79,947,200.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$86,000 | |
| Supplemental Agreement for work within scope | -$830,800 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $30,867,660 | |
| Definitize Letter Contract | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $49,996,340 |
About this award
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $79,947,200.00 Firm Fixed Price contract to Elusys Therapeutics Inc. for the manufacture and vendor managed inventory of Anthim (obiltoxaximab) 600mg/6ml for Injection, an FDA-approved anthrax antitoxin. The contract has a period of performance from August 6, 2021 through September 14, 2024, and includes options for additional manufacturing and delivery of finished drug product and bulk drug substance. The contractor will be responsible for manufacturing, warehousing, inventory management, and distribution of the anthrax antitoxin to replenish and sustain the Strategic National Stockpile. This sole source contract was awarded under FAR 6.302-3(a)(2)(i) and has no set-aside designation.
Quick answers
Who was awarded contract 75A50121C00073?
75A50121C00073 was awarded to Elusys Therapeutics Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 6, 2021.
How much is contract 75A50121C00073 worth?
The government has obligated $79,947,200 on 75A50121C00073.
Was contract 75A50121C00073 competed?
The extent of competition for 75A50121C00073 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award